SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening

Acta Oncologica

Volumn 45, Issue 5, 2006, Pages 536-543

  Emdin, Stefan ^a,h   Granstrand, Bengt ^a   Ringberg, Anita ^b   Sandelin, Kerstin ^c   Arnesson, Lars Gunnar ^d   Nordgren, Hans ^e   Anderson, Harald ^b   Garmo, Hans ^f   Holmberg, Lars ^f   Wallgren, Arne ^g  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^f UPPSALA UNIVERSITY   (Sweden)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^h UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER SURGERY; CAUSE OF DEATH; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUCTAL CARCINOMA IN SITU; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; METASTASIS; POPULATION RESEARCH; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT;

BREAST NEOPLASMS; CARCINOMA IN SITU; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY, ADJUVANT; RECURRENCE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SWEDEN; TREATMENT OUTCOME;

EID: 33746772725     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860600681569     Document Type: Article

References (16)

1. Aspegren K, Holmberg L, Adami HO. Standardization of the surgical technique in breast-conserving treatment of mammary cancer. Br J Surg 1988;75:807-10.
2. Moher D, Schulz KF, Altman DG. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. Lancet 2001;357:1191-4.
3. ICRU: Prescribing and Reporting Photon Beam Therapy. Report # 50. Washington: International Commission on Radiation Units and Measurements; 1993.
4. Consensus conference on the classification of ductal carcinoma in situ. Human Pathology 1997;28:1221-5.
5. Tavassoli FA, Norris HJ. A comparison of the results of long term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990;65:518-29.
6. Elston CW, Ellis IO. The Breast. Systemic Pathology 13. Edinburgh: Churchill Livingstone; 1998.
7. Machin D, Campbell MJ. Statistical tables for the design of clinical trials, 2nd ed. Oxford: Blackwell Science; 1997.
8. Kalbfleisch DL, Prentice RL. The statistical analysis of failure time data, 2nd ed. New York: John Wiley; 2002.
9. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project Protocol B-17. Cancer 1995;75:1310-9.
10. Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-71.
11. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6.
12. Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC RT Group. Lancet 2000;355:528-33.
13. Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: Randomised controlled trial. Lancet 2003;362:95-102.
14. Ringberg A, Moller T. Accrual rate-limiting factors in a Swedish randomised ductal carcinoma in situ (DCIS) trial - a demographic study. Eur J Cancer 2000;36:483-8.
15. Veronesi U, Volterrani F, Luini A, Saccozzi R, Del Vecchio M, Zucali R, et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 1990;26:671-3.
16. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-52.